医疗人工智能即将向模块化架构演进_第1页
医疗人工智能即将向模块化架构演进_第2页
医疗人工智能即将向模块化架构演进_第3页
医疗人工智能即将向模块化架构演进_第4页
医疗人工智能即将向模块化架构演进_第5页
已阅读5页,还剩13页未读, 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

November2025

HealthcarePractice

ThecomingevolutionofhealthcareAItowarda

modulararchitecture

ThesurgeintheuseofAlhealthcaretoolsislikelytopromptashiftawayfrompointsolutions.Earlyinvestorswillsetthefoundationforanintegratedarchitectureandclinical-datafoundries.

AIhascapturedthezeitgeist,andhealthcareorganizationsnowhaveanoverwhelmingnumberofAIsolutionstochoosefrom.Confrontedwithdeepstructuralchallenges,suchaslabor

shortages,risingcarecosts,andpersistentmargincompression,it’snosurprisethatwidespreadadoptionofAI-enabledpointsolutions(applicationsthatimproveasingleactivityortask)from

healthcareservicesandtechnology(HST)companieshastakenoff.

Indeed,it’sanembarrassmentofriches.AIsolutionsareproliferatingfasterthanmost

organizationscanabsorbthem,pressuringhealthcareorganizationstoevolvehowtheywork.Themosteffectiveorganizationswillactlocalbutthinkenterprise-widebyplacingfocused

betsondeeplytacticalAIapplicationswhilereimaginingbusinessdomains.ThenexthorizonofinnovationwillemergefromtheconvergenceofagenticAI,streamlineddataconnectivity,andcross-functionalcoordinationforenterprisetransformation.

WebelievethiswaveofAIinnovationispoisedtosparktwocriticalshiftsthatmany

stakeholdersmaynotyetbeconsideringbutshouldbeginpreparingfornow.First,leaders

willlaythegroundworkforamodular,connectedAIarchitecturethatbringstogetherpoint

solutions,datainfrastructure,andintelligentagentsintoacohesivewhole.Second,thiswill

createopportunitiesforhealthcareorganizationstoconverttheirvaststoresofpatientrecordsintokeyenablersbycreatingclinical-datafoundries,whichcanspurinnovation,improve

clinical-caredeliveryandpatientoutcomes,andunlocknewsourcesofvalue.Datagovernancewillbeatthecoreofboth,andorganizationsthattakeestablishstronggovernanceframeworkswiththeappropriateriskguardrailsearlyontoensureprivacyandconfidentialitywillbeabletodeliversustainedoutcomes.

Realizingthispotentialwillrequiremorethanadoptingnewtoolsandtechnologies.Therush

towardpointsolutionshascreatedafragmentedAIenvironmentandnewoperationalfriction.

Unlessleaders’coursecorrectnow,theywillmerelyautomatetoday’sinefficiencies.HealthcareorganizationsthatinvestnowinredesigningcorebusinessdomainsandprocessesforAI-nativeworkflowswillbebestpositionedtocaptureenterprisevalueanddelivereffectiveclinical

outcomes.Stakeholdersinhealthcareorganizationsareatastrategiccrossroads:Willthey

remainpassivesellers,buyers,andusersofthird-partytools,orwilltheybecomeactiveshapersoftheflexible,integratedhealthcareAIarchitecturethat’snowatantalizingpossibility?

Thisarticleexploreshowemerginginnovations,evolvingprofitpools,andearlysignalsofchangewillpotentiallyshapethehealthcarelandscape.HealthcareAIisshiftingfromtactical,workflow-specifictoolstofederated,modulararchitectureandclinical-datafoundries.Consequently,therealbattlegroundwillbewhocontrolsthedataandorchestrationlayers.

Thenexthorizonisamodular,connectedAIarchitecture

Pointsolutionsarewinningbecausetheyaddressrealworkflowfrictionwithspecificityand

delivertangible,near-termvaluewithinthedomainsthey’reappliedto(seesidebar“Thesuccessofpointsolutions”).Butthey’realsocreatinganewfragmentationproblem.Therefore,thelong-termopportunityliesinassemblingthesecapabilitiesintoamodular,connectedAIarchitecturethatcancoordinatepointsolutionsacrossworkflowsanddomains.

ThecomingevolutionofhealthcareAItowardamodulararchitecture2

ThecomingevolutionofhealthcareAItowardamodulararchitecture3

Thesuccessofpointsolutions

Overthepastfewyears,healthcare

organizationshavebeendeployingAIinareaswithclearfunctionalimpactand

scalability.Herearesomeexamplesof

successfulpointsolutionsandhowAI

enablementhasspurredauthorizationsbytheUSFoodandDrugAdministration(FDA)andinvestments.

Provensolutions

Pointsolutionshavebeenworkingbecausethey’rebuiltforhealthcare’sdeepverticalworkflowsandhelpsolveoperational

constraints.AI-enabledambient-listeningtools,forexample,integrateseamlessly

intoadministrativeandclinicalworkflows

andarebeingadoptedbyhundredsofcareorganizations.AmbientAIhelpedalarge,

California-basedhealthsystemsavenearly16,000hoursindocumentationtimeovera15-monthperiod.1

Additionally,theuseofAIinclinical

decision-makinghasgainedtractionin

areaslikecardiologyandradiology.Tools

likethosefromChatMDandOpenEvidencehaveenabledcareorganizationstorapidlyaccessclinicalguidelinesandpeer-

reviewedliteratureinrealtimetohelpthemanswercomplexquestionsduringcare

deliverytoenhancediagnosticconfidence.Whilehuman-in-the-loopoversight

remainsessential,AIisincreasinglyvaluablewithinclinicaloperations.

AIhasalsobeenappliedtofunctionsof

operationsandrevenuecycleteams,fromschedulingandintaketoclaimsprocessinganddocumentworkflows.Furthermore,

AI-poweredstaffingplatformshavehelped

careorganizationsfillshiftsandreducerelianceonagencylabor,contributingtogreaterworkforcestabilityand

costsavings.2

Healthinsurershaveimplemented

chatbotsacrossavarietyofduties,such

asbenefitandclaimsexplanation,triage

ofmemberrequests,andmatchingof

memberswithin-networkproviders.

Payersarealsoworkingwithvendors

ofelectronichealthrecordstoenhance

providercollaborationstoimprovecare

coordination,reducecoveragegaps,

andstreamlineclaimsprocessingwith

AItools.However,theuseofAItoolsfor

priorauthorizationhasledtoprovider

andmemberconcerns,withtheUS

CentersforMedicare&MedicaidServicesissuingguidanceonprior-authorization

automation.3

Lifescienceorganizationshavealso

deployedAIacrossthevaluechain,from

discoverytocommercialization.ExamplesincludeAIStructuralBiologyNetwork

andOpenFoldConsortium’sOpenFold3,

whichisafederateddata-sharingplatformdevelopedtouseproprietarydatasets

frompharmacompaniestoadvancedrugdiscovery;F.Hoffmann-LaRoche’sdigitalpathologyplatformthathosts20-plus

AIalgorithmsforcancerresearchand

detection,givingpathologistsaccess

tothird-partyinnovation;Novartis’suseofAIforclinical-trialfeasibilityandsiteselection;Amgen’suseofdeepmachinelearninginmanufacturingtoimprove

qualitycontrol;andpharmacompanies

filingregulatorysubmissionsthreetimesfasterbyusingAItools.4

Backedbythemarket

ThesurgeinAIinnovationinUShealthcareisreflectedintheFDAauthorizationof

morethan1,000AI-enabledmedical

devicesbetween2015and2024(exhibit).

Almost80percentoftheseareinmedicalimaging,particularlyradiology,ultrasound,andcomputedtomographyapplications.5

Overthesameperiod,approximately2,400AI-enabledhealthcare-relatedcompanieslaunched.Roughly1,750ofthosewere

backedbyventurecapital,andactivity

beforeventurefundingalsopickedup,

particularlybetween2023(85companies)and2024(155companies),whichpoints

tocontinuedmomentumandearly-stageinterest.6Investmentiskeepingpace:

Between2023and2024,healthcare-AI-venturefundingrosebynearly20percent,andearly2025datasuggestcontinued

growth.Whiledealvolumesremain

modest,averagechecksizesareclimbingsharply,withagrowingshareofcapital

concentratedinlarge-scalebets.

AIholdsthepromiseofbecomingthe

engineofhealthcareproductivity,and

thewaveofAImegarounds(fundingof

atleast$100million)in2025reflectsa

strategicpivotfromstand-alonetoolsto

workflowplatforms.Thelargestfinancingsofarthisyearwas$210millioninSeriesBfundingforOpenEvidence,whichhasanAI-poweredmedical-informationsearch

toolandhasbeenpositioningitasa

system-levelinterfaceforevidence-based

1GilesBruce,“16Khourssaved:AmbientAIscribesatKaiserPermanente,”Becker’sHealthIT,June13,2025.

2Formore,see“UsingAItocreateworkschedulessignificantlyreducesphysicianburnout,studyshows,”AmericanSocietyofAnesthesiologistspressrelease,January28,2022,andNadineBienefeld,EmanuelaKeller,andGudelaGrote,“AIinterventionstoalleviatehealthcareshortagesandenhanceworkconditionsincriticalcare:

Qualitativeanalysis,”JournalofMedicalInternetResearch,January2025,Volume27.

3Formore,see“CMSInteroperabilityandPriorAuthorizationFinalRule(CMS-0057-F),”USCentersforMedicare&MedicaidServices,January17,2024;JenniferLubell,“HowAIisleadingtomorepriorauthorizationdenials,”AmericanMedicalAssociation,March10,2025;andSusannaVogel,“LawmakersscrutinizeAI’sroleinprior

authorization,mentalhealthcareinHousehearing,”HealthcareDive,September4,2025.

4Formore,see“Amgen’sdeeplearningapproachtovialinspection,”PharmaceuticalOnline,March31,2025;MarieRoehm,“AISBnetworkexpandsFederatedOpenFold3Initiativewiththreenewpharmacontributors,”Apheris,October1,2025;MoeAlsumidaie,“HowNovartisisusingAIforclinicaltrialfeasibilityandsiteselection,”ClinicalTrialVanguard,December30,2024;“Rewiringpharma’sregulatorysubmissionswithAIandzero-baseddesign,”McKinsey,August1,2025;“RocheadvancesAI-drivencancerdiagnosticsbyexpandingitsdigitalpathologyopenenvironment,”Rochepressrelease,September9,2024.

5“Artificialintelligence-enabledmedicaldevices,”USFoodandDrugAdministration,July10,2025.

6PitchBook,accessedOctober2025.

ThecomingevolutionofhealthcareAItowardamodulararchitecture4

Thesuccessofpointsolutions(continued)

clinicaldecision-making.7Thecompanyhassinceraisedanother$200millioninSeriesCfunding.8AnotherexampleisAidoc,whichraised$150millionas

itscalesitsFDA-clearedsolutionsin

cardiovascularcare,oncology,andrib

fracturetriage.9ThebackingfrommajorhealthsystemsandNvidia’sventurearm

signalsgrowingconfidenceinAI’sroleinclinical-decisionsupport.

Exhibit

AriseininnovationinUShealthcareAIisevidentinthenumberofrelated

authorizationsandstart-upsandtheincreaseinlater-stageventurecapital.

AIintheUShealthcaresector

300

NumberofFDA1authorizationsofAI-enabledmedicaldevices

250

200

150

100

50

0

200

300

20152024

250

150

100

50

0

NumberofAIhealthcarecompaniesfounded2

20152024

AIhealthcareventurecapitalactivity,2$billion

4.4

2.9

0.9

0.6

Laterstage

Earlystage

Seedround

5.2

3.2

1.4

0.6

2023

2024

4.8

3.6

0.9

0.3

20253

1USFoodandDrugAdministration.

2Excludespharmaceuticalandbiotechnologycompanies.3ThroughJune2025.

Source:FDA;PitchBook

McKinsey&Company

7“OpenEvidence,thefastest-growingapplicationforphysiciansinhistory,announces$210millionroundat$3.5billionvaluation,”OpenEvidencepressrelease,July15,2025.

8MichaelJ.delaMerced,“OpenEvidenceraises$200millionforaChatGPTformedicine,”NewYorkTimes,October20,2025.

9“AidocsecureslandmarkFDAclearanceforfirstfoundationmodel-poweredclinicalAIsolutionofitskind,”Aidocpressrelease,February18,2025;HeatherLandi,“ClinicalAIcompanyAidoclands$150MbackedbyGeneralCatalyst,Nvidia’sventurearm,”FierceHealthcare,July23,2025.

Amodulararchitecturewouldcombineseveralkeylayers:domain-specificAImodelsthatexcelinparticularfunctions,intelligentagentsactingasconnectorsthatcoordinateinteractions

amongthesemodels,andprotocols—suchastheModelContextProtocol(MCP)—thatenablesecure,real-timeaccesstodatawhereeveritresides.Together,thesecomponentscreatean

architecturethatlinksworkflowsbothwithinandacrossdomains.Organizationsthatbuildan

interoperablearchitecturewillcutthetimefromimplementationtoimpact,loweradministrativeburden,andreducerevenueleakage.

ThecomingevolutionofhealthcareAItowardamodulararchitecture5

Investors’currentposition

GiventheproliferationofAItools,investorsarerethinkinghowtodifferentiateopportunities

inanincreasinglycrowdedfieldandarebecomingmoreselectiveaboutwhereandhowthey

placecapital.Exittimelinesremainuncertain,promptingmanyfundstoprioritizecompanies

withembeddeddistribution,integrationreadiness,andthepotentialtobecomeplug-in

assets.Somearealsopursuingnontraditionalplays,suchasmodelsalignedwithpayersand

providers,infrastructure-adjacenttools(forexample,claimsAPIsandorchestrationlayers),

and“rollups”ledbyprivateequitythatcreatesynergisticecosystems.Inthiscontext,diligenceextendsbeyondproductstrengthtoincludeecosystempositioning,integrationvelocity,and

long-termdefensibility.

Competitivedynamics

Recentproductannouncementsfrommajorelectronic-health-record(EHR)companieshave

intensifiedthepressureonAIpointsolutionproviders.1AIcapabilitiesnativetoEHRcompaniesrangefrompatientengagementtoolsandscribestorevenuecyclemanagement,analyticsthatconnectandcontextualizepatientdata,andsolutionsforclinical-trialmanagementanddata

sharing.Thesearepoisedtoacceleratenaturalselectionandconsolidation,reshapingthe

competitivelandscape.AImayevenbecomethecatalystthatredefinesnotonlyEHRmarketdynamicsbutalsotheecosystemofpointsolutionvendorsthemselves,asvendorsarelikelytogravitatetowardEHRplatformsthatpromotemultivendorinteroperabilityandenable

providerchoice.

DespitethestickinessofEHRworkflows,themagnitudeofchangemanagementrequired

suggestsit’sstilluncertainwhetherAIwillreinforceentrenchedproprietary,EHR-native,

potentiallyvendor-lockedsystemsorwilltipthebalancetowardamarketplacemodelfor

pointsolutionvendors.However,whilethefieldforHSTcompanieswillinevitablyconsolidate,it’sunlikelythatanysingleplatformcandeliveracrossalldimensions,andsolutionswithtruedifferentiationarewellpositionedtothrive.AIsolutionswithproventraction,frictionless

workflows,agiledevelopmentcycles,andcleardifferentiationfromEHR-nativetoolshavethepotentialtowithstandthepressure.

Thedecisionsprovidersface

CareorganizationsmaypreferEHR-nativesolutionsfortheirsimplifiedprocurement,integratedworkflows,andminimaldeploymentburden,buttheyremaincautiousaboutoverdependence

onasingleplatform.Furthermore,concernsaboutinnovationpace,thetransitionfrompilots

tofulldeployment,andaccesstocutting-edgetechnologies—oftenpioneeredbyAI-native

HSTcompanies—willsustaindemandforstrongpointsolutions.Thishasbeenillustratedby

OpenEvidence,whichrecentlylaunchedano-costofferingtoverifiedprovidersthatcombinesAI-poweredambientlisteningwithinsightsfromthelatestclinicalliterature.Ultimately,the

healthcareAIlandscapewillbeshapedbythejuxtapositionofEHRincumbents’methodof

proceedingwithAIintegration,HSTvendors’continuedingenuityandinnovationagility,andtheenduringrealitiesoftechnologyadoptionandchangemanagementinhealthcare.

Payer–provider‘botwars’

Anintriguingdynamicisalsoemergingbetweenhealthinsurersandcareproviders.While

providersdeployAItostreamlineclinicaldocumentationandautomatebothpriorauthorizationandclaimsprocessing,payersareadoptingsimilartoolstoverifyclaimsandmanagedenials.

1Formore,seeAshleyCapoot,“EpictoutsnewAItoolsforpatientsanddoctorsatcompany’sannualmeeting,”CNBC,August20,2025,and“OracletobringnewAIcapabilitiestoitspatientportal,makingiteasierforpeopletounderstandtheirmedicalrecords,”Oraclepressrelease,September10,2025.

ThecomingevolutionofhealthcareAItowardamodulararchitecture6

Thisevolvinginterplayhasbeendescribedas“botwars,”withpayerandprovideralgorithms

attimesconflictinginautomatedworkflows.AlthoughpayersadoptedAIsolutionsearlyonforutilizationmanagementandpayments,thepaceofadoptionamongproviderssuggeststhat

payerswillneedtorethinkandredesignprocessesandworkflowstomatchthelevelofefficacyandprecisionthatAIpromisestobringtotheclaimsprocess.

Thehopeisthatthebotwarswillresultinpayer–providersystemsthatarriveattheright

answersmorequicklyandmoreoftensothatmanualinterventionisgenerallylimitedtoonlya

fewcomplexsituationsthatarequicklysurfacedtothehumaninthelooptoresolve.Thisshouldreducefrictionandenablefaster,moreaccurateoutcomes.Andwhenambientlisteningand

AI-enabledclaimsprocessingbecomeomnipresent,thequalityofsolutions,theunderlying

modelstheyweretrainedon,andthedatathatenablethiswillbethetruedifferentiators.Inthisenvironment,successwilldependonthestrengthofunderlyingenablers—namely,high-qualitydata,robustgovernance,traceability,transparency,andsystem-leveldesign.

Theroleofhyperscalersintheevolvinglandscape

Astheimportanceofhigh-qualitydataandtheneedforascalableAIinfrastructureincrease,

techgiantsarerapidlyexpandingtheirpresenceinUShealthcare.Nolongerjustinfrastructureproviders,they’repositioningthemselvesastheoperatinglayerforhealthcareAIbydevelopinghealthcare-specificcloudplatforms,clinical-documentationtools,andclinical-workflow

solutions.2Nvidia’scollaborationwiththeMayoFoundationforMedicalEducationandResearch(MayoClinic)tobuildtheMayoClinicDigitalPathologyplatformandGoogleDeepMind’swork

onMedGemma,adedicatedopenmodelforhealthcare-relatedAIdevelopment,aretwo

prominentexamples.3TherecentproductrolloutsbyEHRcompaniescouldfurtherstrengthentheirposition.Forexample,onemajorEHRincumbent’srecentlyreleasedAIscribeisbuiltin

collaborationwithahyperscaler.4Othersareimplementinglargelanguagemodels(LLMs)fromamajortechnologycompanyorAI-poweredsearchsummariesintheirpatientportals.5

Lookunderneaththehood,andhyperscalersarealsodefiningorchestrationprotocolsandinteroperabilitystandardsthatwillgovernhowintelligenceflowsacrosssystems.Open

architectures,suchasMCP,areallowingnewAIagentstodirectlyaccessfunctionaldata

acrosscareorganizations.Thisreducestheneedforlegacydatalakes,enablescontext-

awareworkflows,streamlinestheuseofdedicatedhealthAImodels,andallowsLLMstobeincorporatedintovariousworkflows.

Inparallel,theUSCentersforMedicare&MedicaidServices(CMS)interoperabilitymandates,

alongwiththeformationoftheCMSInteroperabilityFrameworkandCMS-AlignedNetworks,arereinforcingthisshifttowardopenarchitectureandstandardizeddataflowsacrossthehealthcareecosystem.6Thishasthepotentialtobringaboutabroadershiftfromfragmented,task-specificsolutionstoenterprise-wideAIintegrationthatsupportsfasterinnovation,greaterscale,and

moretargetedcaredelivery.Ratherthanhavingonecentralizedsystem,thefutureofhealthcareAIislikelytobemodular,AI-nativearchitecturethatintegratesagenticAImeshandenables

interoperabilityacrosssiloedsystems.

2NaomiDiaz,“TechgiantspushfurtherintohealthcareAI,”Becker’sHealthIT,April3,2025.

3Formore,see“Nvidiapartnerswithindustryleaderstoadvancegenomics,drugdiscoveryandhealthcare,”Nvidiapressrelease,January13,2025.

4Formore,seeHeatherLandi,“EpicunveilsAIsolutionsforclinicians,patientsandRCM,givessneakpeekatCosmosAIforriskprediction,”FierceHealthcare,August19,2025.

5Formore,seeLauraDyrda,“Oracle,OpenAIdigdeepforpatientempowerment,”Becker’sHealthIT,September11,2025.

6USCentersforMedicare&MedicaidServices’interoperabilitymandatesinclude,butarenotlimitedto,dataexchange

requirementsundertheTrustedExchangeFrameworkandCommonAgreementandtheFastHealthcareInteroperabilityResourcesstandard.Formore,see“CMSInteroperabilityandPriorAuthorizationFinalRuleCMS-0057-F,”Centersfor

Medicare&MedicaidServices,January17,2024.

ThecomingevolutionofhealthcareAItowardamodulararchitecture7

Theemergingopportunityofclinical-datafoundries

AIhealthcaremodelswillbebuiltoncurated,high-qualityclinicaldata.Accesstolongitudinal

clinicaldata,therefore,islikelytoemergeasacorecompetitiveadvantage.Hyperscalersare

startingtocollaboratewithhealthcareorganizationstounlockinsightsfromdeepclinicaldatasets—withoutcompromisingpatientprivacy—underscoringthepivotalrolehealthsystemsplayinrealizingthisopportunity.

ThetoptenhealthsystemsintheUnitedStates(bynumberofhospitals)operatemorethan

1,200hospitalswithnearly175,000beds,givingthemsubstantialcontroloverlongitudinal,high-qualityclinicaldata.7Whilemakingsenseofstructuredandunstructureddatahastraditionally

beentough,genAIandagenticAIcantransforminputsintousable,structuredformats.This

capabilityopensentirelynewwaysforhealthsystemstotransformtheirdataassetsintoasourceofstrategicstrengthbycreatinganewprofitpool.

HealthsystemsorAI-enableddataaggregatorscouldlicensede-identifieddatasets,with

patientconsentandunderpinnedbyrobustdatagovernance—whatwecall“datafoundries”—formodeltrainingtoHSTcompanies.Ortheycouldenterrevenue-sharingpartnershipswithpharmaandmedtechcompanies.ThiscouldspurtheevolutionofanewarchetypeofHSTcompanywithabusinessmodelfocusedondevelopingproprietaryAItoolsinpartnershipwithhealthsystemsandrootedinlocalpopulations.

Theroadaheadwon’tbestraightforward,however.AmajorEHRcompany’srecent

announcementaboutbuildingfoundationmodelsonitsde-identifieddatabasemayfurther

reinforcethisdynamic.Despitethisdatabase’ssubstantialscale,lessthan40percentofhealthsystemsthatusetheEHR,bysomeestimates,contributetheirdata.8Thisleavessufficient

spaceforhealthsystemsandanemergingsetofHSTcompaniestoplayanactiveroleinthe

developmentandmonetizationofclinical-datafoundries,wherehealthsystemscanshapethetermsofagreementforusingtheirdata.

WhilemanyAI-enabledHSTcompanieshavebuiltpointsolutionsthatsolvecomplexcare

andadministrativechallenges,thearchetypeofafull-fledgedclinical-datafoundrycapable

ofcombiningdeviceoutputs,diagnosticresults,genomicdata,pharmacyandclaimsdata,

physiciannotes,andtrialregistrieshasyettofullyemerge.Executiondependsonnotjust

regulatorycompliancebutalsobuildingrobustdatagovernance,fosteringpatientandcliniciantrust,andaligningincentivesacrossstakeholderstoensurelong-termvaluerealization.

Governance,inparticular,loomsasacriticaldifferentiator.MultidisciplinaryAIteamsareneededfortheiroversightandauthorityoverriskassessment,clinicalvalidation,andvendors.9Withouttheseguardrails,there’sariskofregulatoryexposure,resistancefromcareorganizations,and

safetyissues.

7EthanPopowitz,“Top10largesthealthsystemsintheUS,”DefinitiveHealthcare,April4,2025.

8HannahNelson,“HowEpic’sCosmossupportedclinicalresearchwithde-identifieddata,”XtelligentHealthcareMarketing,February2,2022.

9AgustinaD.Saenzetal.,“EstablishingresponsibleuseofAIguidelines:Acomprehensivecasestudyforhealthcareinstitutions,”npjDigitalMedicine,November2024,Volume7,Number1.

ThecomingevolutionofhealthcareAItowardamodulararchitecture8

CareorganizationsanddataaggregatorswithnativehealthcareAImodelshavetheopportunitytoshiftclinicaldatafromapassiverecordtoanactiveasset—monetized,integrated,and

deployedthroughoutdomainstosupportdecision-makingacrossthehealthcarevaluechain.

Theemergenceofclinical-datafoundriesmaydefinethenextmajorprofitpoolinhealthcare,andthosewhocurateandactivatetheseassetswillshapetheeconomicsofthehealthcare

AIecosystem.

Recommendationsforstakeholders

TherapidevolutionofAIinhealthcareisreshapingtheindustry,creatingdistinctopportunitiesandimperativesforallparties.Eachgroupbringsdistinctcapabilitiesandpriorities,yettheir

choiceswillcollectivelydeterminehowquicklyinnovationscalesandintegratesintoclinical

practice.Hereweproviderecommendationsforinvestors,HSTcompanies,hyperscalers,andstrategiccompanies(seesidebar“RecommendationsforhealthcareCEOs”).

Investorsandhealthcareservicesandtechnologycompanies

Investorsshouldprioritizenear-termopportunitieswithHSTcompanieswhoseAI-enabled

pointsolutionsdemonstratecleartractionandscalableusecasesandwithprovensuccessinnavigatingthecomplexprocurementenvironmentinhealthcare.HSTcompaniesshould,overtime,expandintoplatformsolutions,attractingcapitalandfacilitatingstrategicrollupsand

partnershipswithlargetechnologycompaniesorhealthsystemsthatarewellpositionedtoshapetheemerginghealthcareAIarchitectureandclinical-data-foundryopportunity.

Inthelongrun,themostsuccessfulexitsarelikelytocomefromcompaniesthatarebuildingecosystemsratherthanstand-alonetools.AshealthcareorganizationstreatAIenabledpointsolutionsasonrampstothemodularAIarchitectureandclinical-data-foundrystrategy,

organizationsshouldpickprioritydomainsandredesignthemendtoendforAIintegrationasopposedtofragmentedpilots.

OrganizationsthatsequencetheirstrategyfromhighROIpointtoolstoaconnectedarchitectureacrossdomainswillbebestpositionedtoleadinthedevelopmentofclinical-datafoundriesandcreateanddelivervalue.Inparallel,theseorganizationsshouldbuildarobustmultidisciplinary

datagovernanceframeworkthatcatalogsstructuredandunstructuredassets,definesdata

RecommendationsforhealthcareCEOs

ForCEOsacrossthehealthcarevaluechain,wesuggestthefollowing:

—Proveit,thenscaleit.Startwhere

ROIisimmediate.Deployagentic

AItoownfullworkflows(such

asdocumentation,patient

communicat

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论